Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis
Myelin-specific induction of tolerance represents a promising means to modify the course of autoimmune inflammatory demyelinating diseases such as multiple sclerosis (MS). Our laboratory has focused on a novel preclinical strategy for the induction of tolerance to the major encephalitogenic epitope...
Main Authors: | Mark D. Mannie, J. Lori Blanchfield, S. M. Touhidul eIslam, Derek J. Abbott |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2012.00255/full |
Similar Items
-
Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination
by: Carsten Tue Berg, et al.
Published: (2017-06-01) -
Swimming Exercise Ameliorates Symptoms of MOG-Induced Experimental Autoimmune Encephalomyelitis by Inhibiting Inflammation and Demyelination in Rats
by: Ji-Youn Kim, et al.
Published: (2020-05-01) -
Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease
by: Shinji Yamamoto, et al.
Published: (2017-07-01) -
Rodent Models of Optic Neuritis
by: Yael Redler, et al.
Published: (2020-11-01) -
Evaluation of IL-17 Serum Level, Brain Inflammation and Demyelination in Experimental Autoimmune Encephalomyelitis C57BL/6 Mice Model with Different Doses of Myelin Oligodendrocyte Glycoprotein
by: Mohammad Mehdi Ghorbani, et al.
Published: (2019-06-01)